Zymo Research Pledges to End COVID-19 Pandemic in India | New

IRVINE, Calif., September 28, 2021 / PRNewswire / – Zymo Research Donated One Million COVID-19 Test Kits That Include Its New DNA / RNA Shield – DirectDetectâ„¢ reagents and collection devices at Mapmygenomeâ„¢ situated at Hyderabad, India. Mapmygenome is a molecular diagnostics company that provides customers with personalized DNA testing, COVID-19 testing, and genetic counseling. It offers its clients personalized health solutions based on genetic tests. They have provided COVID-19 testing throughout the pandemic at their state-of-the-art, cGLP-compliant molecular testing laboratory as well as an on-site laboratory at Rajiv Gandhi International Airport in Hyderabad, India where they test incoming passengers for the SARS-CoV-2 virus.

DNA / RNA Shield – DirectDetect, a reagent similar to the established DNA / RNA shield from Zymo Researchâ„¢, protects viral RNA from degradation for safe, room-temperature collection and transport of samples without the need for nucleic acid extraction. Eliminating the nucleic acid extraction step reduces the time to obtain PCR test results. Compared to other reagents, DNA / RNA Shield – DirectDetect does not inhibit downstream RT-PCR. The DNA / RNA Shield Test Kit – DirectDetect contains the DNA / RNA Shield Reagent – DirectDetect with swab collection devices.

“DNA / RNA Shield – DirectDetect Enables Countries With Increased COVID-19 Cases To Perform COVID-19 Testing Without Extraction; hence, eliminating the barrier of limited extraction resources. It is our way of providing humanitarian support to those in need, ”said Dr. Marc Van Eden, vice president of business development at Zymo Research. “We have partnered with Mapmygenome because of their ability to rapidly deploy and analyze RT-PCR assays. “

“In India, where testing supplies and vaccinations are hard to come by, testing is imperative to diagnose the SARS-CoV-2 virus,” said Anu Acharya, Founder and CEO of Mapmygenome. She continued, “While many biotech and test vendors have tended to focus on their domestic testing efforts, we appreciate Zymo Research’s global humanitarian effort to help eradicate COVID-19. “

For more information on DNA / RNA Shield – DirectDetect and the Zymo Research Donation Program, visit their website.

About Zymo Research Corp.

Zymo Research is a privately held company that has served the scientific and diagnostic community with advanced molecular biology tools since 1994. The company’s vision “The beauty of science is to make it simple” is reflected in all of their products, from epigenetics to DNA / RNA purification technologies. Historically recognized as the leader in epigenetics, Zymo Research pushes the boundaries with new solutions for sample collection, microbiomic measurements, diagnostic devices and NGS technologies that are high quality and easy to use. Follow Zymo Research on Facebook, LinkedIn, Twitter, and Instagram.

View original content to download multimedia: https://www.prnewswire.com/news-releases/zymo-research-pays-it-forward-with-their-commitment-to-eradicate-the-covid-19-pandemic -in -inde-301386263.html

SOURCE Zymo Research Corp.

About admin

Check Also

Deciphering neutrality in humanitarianism – World

In this article, Navya Khanna explores how neutrality hampers decolonization efforts and prevents lasting peace …

Leave a Reply

Your email address will not be published.